Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1977 Jun;126(6):479–484.

The treatment of the nephritis of lupus erythematosus.

PMCID: PMC1237635  PMID: 878467

Full text

PDF
479

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldwin D. S., Lowenstein J., Rothfield N. F., Gallo G., McCluskey R. T. The clinical course of the proliferative and membranous forms of lupus nephritis. Ann Intern Med. 1970 Dec;73(6):929–942. doi: 10.7326/0003-4819-73-6-929. [DOI] [PubMed] [Google Scholar]
  2. Barnett E. V. Letter: Lupus erythematosus: immunosuppressive therapy. Ann Intern Med. 1976 May;84(5):610–610. doi: 10.7326/0003-4819-84-5-610_1. [DOI] [PubMed] [Google Scholar]
  3. Cameron J. S., Boulton-Jones M., Robinson R., Ogg C. Treatment of lupus nephritis with cyclophosphamide. Lancet. 1970 Oct 24;2(7678):846–849. [PubMed] [Google Scholar]
  4. Cathcart E. S., Idelson B. A., Scheinberg M. A., Couser W. G. Beneficial effects of methylprednisolone "pulse" therapy in diffuse proliferative lupus nephritis. Lancet. 1976 Jan 24;1(7952):163–166. doi: 10.1016/s0140-6736(76)91272-1. [DOI] [PubMed] [Google Scholar]
  5. Decker J. L., Klippel J. H., Plotz P. H., Steinberg A. D. Cyclophosphamide or azathioprine in lupus glomerulonephritis. A controlled trial: results at 28 months. Ann Intern Med. 1975 Nov;83(5):606–615. doi: 10.7326/0003-4819-83-5-606. [DOI] [PubMed] [Google Scholar]
  6. Donadio J. V., Jr, Holley K. E., Ferguson R. H., Ilstrup D. M. Progressive lupus glomerulonephritis. Treatment with prednisone and combined prednisone and cyclophosphamide. Mayo Clin Proc. 1976 Aug;51(8):484–494. [PubMed] [Google Scholar]
  7. Donadio J. V., Jr, Holley K. E., Wagoner R. D., Ferguson R. H., McDuffie F. C. Further observations on the treatment of lupus nephritis with prednisone and combined prednisone and azathioprine. Arthritis Rheum. 1974 Sep-Oct;17(5):573–581. doi: 10.1002/art.1780170511. [DOI] [PubMed] [Google Scholar]
  8. Epstein W. V., Grausz H. Favorable outcome in diffuse proliferative glomerulonephritis of systemic lupus erythematosus. Arthritis Rheum. 1974 Mar-Apr;17(2):129–142. doi: 10.1002/art.1780170205. [DOI] [PubMed] [Google Scholar]
  9. Epstein W. V., Shearn M. A. Letter: Immunosuppressive drugs in lupus nephritis. Ann Intern Med. 1976 Apr;84(4):492–493. doi: 10.7326/0003-4819-84-4-492. [DOI] [PubMed] [Google Scholar]
  10. Feinstein A. R. Clinical biostatistics. II. Statistics versus science in design of experiments. Clin Pharmacol Ther. 1970 Mar-Apr;11(2):282–292. [PubMed] [Google Scholar]
  11. Fessel W. J. Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women. Arch Intern Med. 1974 Dec;134(6):1027–1035. [PubMed] [Google Scholar]
  12. Fries J. F., Holman H. R. Systemic lupus erythematosus: a clinical analysis. Major Probl Intern Med. 1975;6:v–199. [PubMed] [Google Scholar]
  13. Hahn B. H., Kantor O. S., Osterland C. K. Azathioprine plus prednisone compared with prednisone alone in the treatment of systemic lupus erythematosus. Report of a prospective controlled trial in 24 patients. Ann Intern Med. 1975 Nov;83(5):597–605. doi: 10.7326/0003-4819-83-5-597. [DOI] [PubMed] [Google Scholar]
  14. Hecht B., Siegel N., Adler M., Kashgarian M., Hayslett J. P. Prognostic indices in lupus nephritis. Medicine (Baltimore) 1976 Mar;55(2):163–181. doi: 10.1097/00005792-197603000-00005. [DOI] [PubMed] [Google Scholar]
  15. POLLAK V. E., PIRANI C. L., SCHWARTZ F. D. THE NATURAL HISTORY OF THE RENAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. J Lab Clin Med. 1964 Apr;63:537–550. [PubMed] [Google Scholar]
  16. Pollak V. E., Pirani C. L., Dujovne I., Dillard M. G. The clinical course of lupus nephritis: relationship to the renal histologic findings. Perspect Nephrol Hypertens. 1973;1(Pt 2)(0):1167–1181. [PubMed] [Google Scholar]
  17. Siegel M., Holley H. L., Lee S. L. Epidemiologic studies on systemic lupus erythematosus. Comparative data for New York City and Jefferson County, Alabama, 1956-1965. Arthritis Rheum. 1970 Nov-Dec;13(6):802–811. doi: 10.1002/art.1780130610. [DOI] [PubMed] [Google Scholar]
  18. Steinberg A. D., Decker J. L. A double-blind controlled trial comparing cyclophosphamide, azathioprine and placebo in the treatment of lupus glomerulonephritis. Arthritis Rheum. 1974 Nov-Dec;17(6):923–937. doi: 10.1002/art.1780170602. [DOI] [PubMed] [Google Scholar]
  19. Wagner L. Immunosuppressive agents in lupus nephritis: a critical analysis. Medicine (Baltimore) 1976 May;55(3):239–250. doi: 10.1097/00005792-197605000-00003. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES